• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过互补DNA克隆证明猪钙蛋白酶抑制蛋白重复结构域结构的证据。

Evidence for the repetitive domain structure of pig calpastatin as demonstrated by cloning of complementary DNA.

作者信息

Takano E, Maki M, Hatanaka M, Mori H, Zenita K, Sakihama T, Kannagi R, Marti T, Titani K, Murachi T

出版信息

FEBS Lett. 1986 Nov 24;208(2):199-202. doi: 10.1016/0014-5793(86)81017-1.

DOI:10.1016/0014-5793(86)81017-1
PMID:3780962
Abstract

A clone of complementary DNA (cDNA) coding for pig heart calpastatin was isolated using synthetic oligonucleotide probes. The amino acid sequence deduced from the nucleotide sequence revealed the occurrence of a repetitive sequence at the interval of 140 amino acids, substantiating the multidomain structure of calpastatin. A portion of the sequence of 251 amino acid residues predicted for pig heart calpastatin (107 kDa) was found to be identical with that of a peptide fragment derived from pig erythrocyte calpastatin (68 kDa) and sequenced by Edman degradation.

摘要

利用合成寡核苷酸探针分离出编码猪心钙蛋白酶抑制蛋白的互补DNA(cDNA)克隆。从核苷酸序列推导的氨基酸序列显示,在每140个氨基酸的间隔处存在重复序列,证实了钙蛋白酶抑制蛋白的多结构域结构。猪心钙蛋白酶抑制蛋白(107 kDa)预测的251个氨基酸残基的部分序列,被发现与源自猪红细胞钙蛋白酶抑制蛋白(68 kDa)并通过埃德曼降解测序的肽片段序列相同。

相似文献

1
Evidence for the repetitive domain structure of pig calpastatin as demonstrated by cloning of complementary DNA.通过互补DNA克隆证明猪钙蛋白酶抑制蛋白重复结构域结构的证据。
FEBS Lett. 1986 Nov 24;208(2):199-202. doi: 10.1016/0014-5793(86)81017-1.
2
Pig heart calpastatin: identification of repetitive domain structures and anomalous behavior in polyacrylamide gel electrophoresis.
Biochemistry. 1988 Mar 22;27(6):1964-72. doi: 10.1021/bi00406a024.
3
cDNA cloning of human calpastatin: sequence homology among human, pig, and rabbit calpastatins.
J Enzyme Inhib. 1989;3(1):49-56. doi: 10.3109/14756368909030363.
4
Analysis of structure-function relationship of pig calpastatin by expression of mutated cDNAs in Escherichia coli.通过在大肠杆菌中表达突变cDNA对猪钙蛋白酶抑制蛋白的结构-功能关系进行分析。
J Biol Chem. 1988 Jul 25;263(21):10254-61.
5
Repetitive region of calpastatin is a functional unit of the proteinase inhibitor.
Biochem Biophys Res Commun. 1987 Feb 27;143(1):300-8. doi: 10.1016/0006-291x(87)90665-6.
6
Bovine skeletal muscle calpastatin: cloning, sequence analysis, and steady-state mRNA expression.
J Anim Sci. 1994 Mar;72(3):606-14. doi: 10.2527/1994.723606x.
7
Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases.系统性风湿性疾病中针对钙蛋白酶抑制蛋白(一种钙依赖性中性蛋白酶——钙蛋白酶的内源性抑制剂)的自身抗体。
Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7267-71. doi: 10.1073/pnas.92.16.7267.
8
Cloning and characterization of the yak gene coding for calpastatin and in silico analysis of its putative product.牦牛钙蛋白酶抑制蛋白编码基因的克隆、特征分析及其推定产物的电子克隆分析
Acta Biochim Pol. 2010;57(1):35-41. Epub 2010 Mar 19.
9
All four internally repetitive domains of pig calpastatin possess inhibitory activities against calpains I and II.猪钙蛋白酶抑制蛋白的所有四个内部重复结构域均对钙蛋白酶I和II具有抑制活性。
FEBS Lett. 1987 Oct 19;223(1):174-80. doi: 10.1016/0014-5793(87)80531-8.
10
cDNA cloning and expression of pig cytosolic aspartate aminotransferase in Escherichia coli: amino-terminal heterogeneity of expressed products and lack of its correlation with enzyme function.猪胞质天冬氨酸氨基转移酶在大肠杆菌中的cDNA克隆与表达:表达产物的氨基末端异质性及其与酶功能的无关性
Biochemistry. 1989 Feb 7;28(3):1153-60. doi: 10.1021/bi00429a033.

引用本文的文献

1
Detecting the active conformation of calpain with calpastatin-based reagents.使用基于钙蛋白酶抑制蛋白的试剂检测钙蛋白酶的活性构象。
Biochim Biophys Acta. 2008 Nov;1784(11):1676-86. doi: 10.1016/j.bbapap.2008.08.013. Epub 2008 Aug 28.
2
Structure and physiological function of calpains.钙蛋白酶的结构与生理功能。
Biochem J. 1997 Dec 15;328 ( Pt 3)(Pt 3):721-32. doi: 10.1042/bj3280721.